Enhanced Liver Fibrosis (ELF™). Package insert. Siemens Healthcare Diagnostics Inc; 2022. Cusi K, Isaacs S, Barb D, et al. American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrino...
Liver fibrosisHyaluronic acidMetalloproteinasesBackground: The Enhanced Liver Fibrosis (ELF) is a serological score that includes hyaluronic acid (HA), tissue inhibitor of matrix metalloproteinases-1(TIMP-1), and aminoterminal propeptide of type III procollagen (PIIINP) and shows good performance for ...
K,Rosenberg W,Vaske B, et al.Biopsy-Controlled Liver Fibrosis Staging Using the Enhanced Liver Fibrosis (ELF) Score Compared to Transient Elastography. Pl... Wahl,Kristin,Rosenberg,... - 《Plos One》 被引量: 42发表: 2012年 Performance of Transient Elastography for the Staging of Liver Fibr...
Moreover, we assessed the diagnostic accuracy (AUROC) of the Enhanced Liver Fibrosis (ELF) score to identify significant fibrosis (F2-4) and its predictive capacity to identify clinical events during follow-up. Seventy-six patients (39,8%) had mild fibrosis (F0-1) and 115 (60,2%) ...
FIB-4 Index Panel with Reflex to Enhanced Liver Fibrosis (ELF) Score - This reflex provides a cost-effective, medically justified, and guideline supported approach to evaluating a patient at risk of NAFLD with liver fibrosis. If the FIB-4 index is ...
Additionally, rats in TAA group that received SOF therapy did not exhibit improved liver functions, TGF-尾1level and liver fibrosis score. However, administering nano-sofosbuvir prophylactically to TAA-treated rats resulted in a considerable improvement in liver function tests, TGF-1 levels, with ...
Knockdown of Mfap4 in hepatocytes enhances cell proliferation, accelerates liver regeneration, and attenuates chronic liver disease by reducing liver fibrosis. Targeting Mfap4 modulates several liver regeneration-related pathways including mTOR. Our research opens the way to siRNA-based therapeutics to ...
Aim To investigate whether the combination of sCD163 as a hepatic inflammation marker and the fibrosis markers of the Enhanced Liver Fibrosis score (ELF) can predict portal hypertension in patients with cirrhosis. Methods We measured sCD163 and the ELF components (hyaluronic acid, tissue inhibitor ...
MR elastography (MRE) for noninvasive staging of liver fibrosis. Methods This single-center retrospective study included 355 patients (M/F 238/117, mean age 60 years; training, n = 178; validation, n = 123; test, n = 54) who underwent gadoxetic acid–enhanced abdominal MRI, including ...
Gadoxetic acid-enhanced MRI has been previously investigated for the staging of liver fibrosis using radiomics analysis10 and a deep convolutional neural network (DCNN)7. To the best of our knowledge, no study to date has proposed that the etiology of liver cirrhosis can be predicted using a ...